乳腺癌筛查中乳腺超声检查和乳腺钼靶检查应用分析比较

Comparison of bbreast ultrasound and mammography in breast cancer screening

目的探析乳腺超声检查和乳腺钼靶检查在乳腺癌筛查中的应用价值。方法回顾性收集2016年9月至2018年4月在我院妇产科就诊的疑似乳腺癌患者中选出500例,均接受乳腺超声检查和乳腺钼靶检查,以手术病理为诊断金标准,收集单一检查与联合检查的诊断符合率、灵敏度、特异度等。结果乳腺超声的诊断符合率、灵敏度和特异度分别为76.4%、81.3%、53.4%,乳腺钼靶检查分别为86.8%、90.0%、71.6%,乳腺超声+乳腺钼靶检查分别为95.0%、97.1%、85.2%,3种方法比较:乳腺超声的诊断符合率、灵敏度和特异度最低,乳腺钼靶居中,超声联合乳腺钼靶检查则最高,3种方法之间差异有统计学意义(P<0.05);在乳腺癌检出率、直径<1.0 cm肿瘤检出率、直径1.0~2.0 cm肿瘤检出率,3种方法对比差异有统计学意义(P<0.05);而在直径在2.1~3.0 cm、≥3.0 cm肿瘤的检出率对比,差异无统计学意义(P>0.05)。结论乳腺超声和乳腺钼靶在乳腺癌筛查中均具有一定价值,联合应用有助于提高乳腺癌早期检出率,值得推广。

Objective To explore the value of breast ultrasound and mammography in screening breast cancer. Methods Five-hundred patients with suspected breast cancer who were admitted to the department of obstetrics and gynecology in September 2016 to April 2018 were retrospectively collected for a total, All of them were examined by breast ultrasound and mammography, and the diagnostic gold standard was the surgical pathology, and the diagnostic coincidence, sensitivity and specificity of the single examination and joint examination were collected. Results The diagnostic coincidence, sensitivity and specificity of breast ultrasound were 76.4%, 81.3% and 53.4% respective-ly. Mammography was 86.8%, 90.0%, 71.6%, and breast ultrasound + mammography was 95.0%, 97.1%, 85.2%, respectively, and three methods were compared: the diagnostic coincidence, sensitivity and specificity of breast ultrasound were the lowest. Breast mammography was in the middle, ultrasound combined with mammography was the highest, and the difference between the three methods was statistically significant(P<0.05).The detection rate of breast cancer, the diameter < 1.0 cm tumor detection rate and the diameter 1.0-2.0 cm tumor detection rate were statistically significant between the three methods(P<0.05),but in the diameter of 2.0-3.0 cm, or more 3.There was no significant difference in the detection rate of 0 cm tumors(P<0.05). Conclusion Breast ultrasound and mammography have certain value in breast cancer screening. Combined application can improve the early detection rate of breast cancer and is worthy of promotion.